[REGN] YoY Annual Result on 31-Dec-2005 [#FY]

Stock
[REGN] Regeneron Pharmaceuticals, Inc.
Announcement Date
28-Feb-2006
Financial Year
2005
Quarter
31-Dec-2005 [#FY]
Profit Trend
YoY- -328.89%
Quarter Report
REGN's Result
REGN's Financial Summary
View:
Show?
Annual Result
31/12/10 31/12/09 31/12/08 31/12/07 31/12/06 31/12/05 31/12/04 CAGR
Revenue 459,074 379,268 238,457 125,024 63,447 66,193 174,017 17.53%
PBT -104,468 -71,952 -80,359 -93,557 -91,107 124,421 53,874 -
Tax -2,122 -4,122 2,351 -29,751 -21,866 178,846 -84,281 -45.84%
NP -104,468 -67,830 -82,710 -105,600 -102,337 -95,446 41,699 -
Tax Rate - - - - - -143.74% 156.44% -
Total Cost 563,542 447,098 321,167 230,624 165,784 161,639 132,318 27.30%
Ratio Analysis
31/12/10 31/12/09 31/12/08 31/12/07 31/12/06 31/12/05 31/12/04 CAGR
NP Margin -22.76 -17.88 -34.69 -84.46 -161.30 -144.19 23.96 -
Per Share
31/12/10 31/12/09 31/12/08 31/12/07 31/12/06 31/12/05 31/12/04 CAGR
EPS -1.26 -0.85 -1.05 -1.59 -1.77 -1.71 0.75 -
EPS Diluted -1.26 -0.85 -1.05 -1.59 -1.77 -1.71 0.74 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.